Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04369690
Other study ID # 2131
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 3, 2020
Est. completion date April 3, 2021

Study information

Verified date April 2020
Source University of Ottawa
Contact Rébecca Robillard, PhD
Phone 613-722-6521
Email rebecca.robillard@uottawa.ca
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A dynamic analytical tool is being implemented to monitor the health, psychosocial and economic impacts of the COVID-19 pandemic as the crisis unfolds. A longitudinal survey is distributed via a network of hospitals, provincial/national organizations and web platforms. The survey information can be linked to provincial health administrative data and metrics derived from social media activity based on artificial intelligence methods. Targeted questions are included for critical populations such as healthcare workers and people with chronic illnesses.


Description:

The current situation unfolding with regards to the COVID-19 virus is changing core aspects of people's lives in a unique manner. This study aims to examine the psychological, social, and financial impacts of the COVID-19 pandemic at various stages of the outbreak.

Individuals 12 years and older are recruited from three main groups: general population, people with chronic illnesses and healthcare professionals.

An online survey is distributed via multiple hospitals, provincial/national organizations, and web-based platforms at various phases of the outbreak. The survey includes validated questionnaires and custom-made questions to asses the current situation. It notably addresses the following themes: demographics, COVID-19 symptoms and diagnoses, social distancing practices and social interactions, living situation, financial situation, family and work-related challenges, access to healthcare, as well as sleep, physical and mental health.

The survey is available in English and French. It is built on a decisional tree structure with customized subsets of questions based on previous answers.The survey contains an adolescent version and an adult version, and also includes targeted questions for individuals with a current diagnosis of a mental/medical illness. Consent is also sought to link data from parent-child dyads to enable finer analyses of family dynamics. Healthcare staff are invited to answer questions about work-related difficulties, usefulness of virtual tools for clinical practice, as well as moral distress and moral resilience in the context of clinical practice. Healthcare staff who are short on time can chose fill out an abbreviated version. Participants have the option of enabling linkage to linked to provincial health administrative data, and to provide their twitter and facebook handle for social media and mood monitoring through artificial intelligence algorithms. Participants have the option of being followed longitudinally during and after the outbreak.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date April 3, 2021
Est. primary completion date April 3, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years and older
Eligibility Inclusion Criteria:

- All individuals who are at least 12 years of age

Exclusion Criteria:

- None

Study Design


Locations

Country Name City State
Canada Hôpital en santé mentale Rivière-des-Prairies (CIUSSS du Nord-de-l'Île-de-Montréal) Montréal Quebec
Canada McGill University Montréal Quebec
Canada University of Montréal Montréal Quebec
Canada Southlake Regional Health Centre Newmarket Ontario
Canada CHEO Research Institute Ottawa Ontario
Canada The Centre for Addiction and Mental Health Ottawa Ontario
Canada The Ottawa Hospital Research Institute Ottawa Ontario
Canada The Royal's Institute of Mental Health Research Ottawa Ontario
Canada The University of Ottawa Heart Institute Ottawa Ontario
Canada Sunnybrook Health Sciences Centre Toronto Ontario

Sponsors (13)

Lead Sponsor Collaborator
University of Ottawa Centre for Addiction and Mental Health, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal, CHEO Research Institute, Hopital du Sacre-Coeur de Montreal, Johns Hopkins University, McGill University, Ottawa Heart Institute Research Corporation, Southlake Regional Health Centre, Sunnybrook Health Sciences Centre, The Ottawa Hospital Research Institute, The Royal's Institute of Mental Health Research, Université de Montréal

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mental health - Stress Cohen's Perceived Stress Scale (scores ranged from 0 to 40, higher scores indicating worse stress) through study completion, estimated to 8 months
Primary Mental health - Anxiety Generalized Anxiety Disorder Scale (scores ranged from 0 to 21, higher scores indicating worse anxiety) through study completion, estimated to 8 months
Primary Mental health - Depression Quick Inventory of Depressive Symptomatology-Self-report, short version (scores ranged from 0 to 27, higher scores indicating worse depression) through study completion, estimated to 8 months
Secondary Moral distress in healthcare workers Measure of Moral Distress - Healthcare Professionals (scores ranged from 0 to 432, higher scores indicating worse moral distress) through study completion, estimated to 8 months
Secondary Moral resilience in healthcare workers Rushton Moral Resilience Scale (scores ranged from 1 to 4, higher scores indicating more resiliency) through study completion, estimated to 8 months
Secondary Social life Frequency of interacting with other people (daily, weekly, monthly, less often than monthly) through study completion, estimated to 8 months
Secondary COVID-9 symptoms Fever, Cough, Difficulty breathing or shortness of breath, Tiredness, Aches and pains, Nasal congestion, Runny nose, Sore throat, Diarrhea (Mild Moderate, Severe, N/A) through study completion, estimated to 8 months
Secondary Adverse health long-term outcome Mortality (Yes/No): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx 5 years before the outbreak and two years after
Secondary Health care utilization - Inpatient Hospitalizations (total number): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx 5 years before the outbreak and two years after
Secondary Health care utilization - ER Emergency Department visits (Total number): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx 5 years before the outbreak and two years after
Secondary Health care utilization - Outpatient Outpatient visits: https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx 5 years before the outbreak and two years after
Secondary Sleep Pittsburgh Sleep Quality Index (scores ranged from 0 to 21, higher scores indicating worse sleep disturbances) through study completion, estimated to 8 months
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure

External Links